Attention Deficit Disorder
(ADD & ADHD) Treatment
Studies show that ADD is caused by damage in specific regions of the central nervous system due to a deficiency in the developmental process, which can generate attention deficit disorder and learning disabilities. ADD can be hereditary.
The problem is due to a hypo development of the mentioned systems during the formation of the central nervous system associated with a high family incidence. This type of attention deficit would be the inattentive type. Other subtypes can be generated by lesions or damages to other regions of the CNS such as the frontal lobe, the anterior nuclei of the thalamus and the basal ganglia. The typical ADD treatment must pretend to favor the development of the dopaminergic and noradrenergic systems for reducing the hypo activity of the mentioned systems that participate in the attentive process.
RCT is using specific peptides, growth factors and neurotrophic factors that carry encoded information to a specific receptor on neurons. This creates a series of intercellular reactions within the neurons. The signals pass through the nucleus of the cell until they arrive to the DNA. These signals stimulate the DNA. When this process is complete the RNA reads the new information and creates a functional protein based on the needs of that particular neuron. This causes the neuron to start functioning normally again.
Neurological disorders can stem from an over abundance or deficiency of neurotrophic factors. The specific neurotrophic factors RCT is using have the ability to regulate the neurons and support normal brain function.
When there are not enough neurotrophic factors being produced, the treatment will stimulate the neurons to produce the necessary levels. When there are too many of these molecules, it will inhibit the production of these neurotrophic factors.
• Read published research on the importance of Neurotrophic Factor levels here.
• Read published research on one of the molecules (IGF2) used in RCT’s treatment.
* RCT is not disclosing the complete set of molecules used in each treatment, in order to protect the process until patents are finalized.
The Neurotrophic Factors are not drugs; they are molecules that reconstitute the Central and Peripheral Nervous System. These contain a peptide, growth factor or neurotrophic factor fraction obtained by chromatography (Proteins extracted with a chromatographic purity greater than 99%). The neurotrophic factors used by RCT are specifically for ADD and ADHD.
Peptide-based treatments have neurotrophic effects on neurons of the central nervous system, stimulating the development, survival and neuritic growth. This promotes neuroplasticity, neuronal maturation and it creates new electrical contacts, known as synaptogenesis, which have transcendent effects. The improvements obtained are permanent and there is no regression of the advancements obtained.
In addition, Fibroblast growth factors can have a stimulating effect on the glutamatergic or pyramidal neurons of the cerebral cortex and other regions of the central nervous system, promoting the survival, development and activity of these types of neurons. Specifically in the frontal, parietal and temporal regions of the cerebral cortex, since these areas are critical for cognitive processes (awareness, recognition, analysis, reasoning, imagination etc.)
The same has proven to be effective in improving the function in learning disorders, such as Dyslexia and Attention Deficit, Autism Spectrum Disorders, Asperger syndrome, Down Syndrome, Cerebral Palsy, and Neuro degenerative Diseases.
David explains his results with the 53 week treatment program.